spacer
home > pmps > summer 2019 > leaving on a jet plane
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Leaving on a Jet Plane

‘Leaving on a jet plane’ is the title of one of John Denver’s greatest hits. However, it is also what an increasing number of pharmaceutical products do every day, when the results of Medicon Valley based R&D, commercialisation, and manufacturing are sent out to make a difference worldwide.

The binational Danish-Swedish life sciences cluster Medicon Valley consists of the Region Zealand, the Danish Capital Region, and the Swedish region Skåne. It is not only host to cutting-edge public and private life sciences R&D in, for instance, oncology, dermatology, diabetes, fertility, and CNS-related diseases, but also the world’s largest insulin manufacturing site owned by Novo Nordisk and located in the Danish city of Kalundborg. Additionally, Medicon Valley-based companies such as LEO Pharma, Baxter, Coloplast, Ferring, and Lundbeck have substantial local production and/or R&D facilities; this makes Copenhagen Airport a central logistics hub and, since it serves Denmark and South Sweden alike, the most important airport in the Nordics from a life sciences perspective.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Petter Hartman is the CEO of Medicon Valley Alliance since June 2015 and holds a Masters in Political Science from the University of Lund, Sweden. At Medicon Valley Alliance, Petter is involved in future strategies for the Medicon Valley region, general management within the public sector, project management, and pharma R&D. Petter comes from a post as Funding Manager at Medicon Valley Alliance. Prior to joining, Petter worked for the Secretariat for Interreg IV A Öresund-Kattegat- Skagerrak, Copenhagen, as a project consultant with special responsibility for issues concerning cross-border relations and labourmarket integration projects.
spacer
Petter Hartman
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Merck Launches ADC ExpressTM Services to Accelerate Pre-clinical Conjugation Candidate Selection

• Provides rapid production of antibody drug conjugates (ADCs) for best candidate selection • Established platform technology to reliably scale target molecules • Reduces time to clinic through comprehensive ADC services from pre-clinical to commercial from a single source
More info >>

White Papers

Clinical Trials in Ukraine: Orange Paper Overview and 1st Half Year 2014

Synergy Research Group

The Orange Paper is an analytical report about the clinical trials market in Russia, published quarterly by the contract research organization Synergy Research Group. The first edition of Orange Paper was released in 2006, and at the moment 31 issues have already published. Now, thanks to Synergy Group Ukraine, obtaining information about the market of clinical trials in Ukraine has become possible. In Ukraine, during the period from 1996 to 2013, applicants had obtained 3,864 positive conclusions about the possibility of conducting clinical trials of drugs, both for domestic and foreign manufacturers, including conduct of multinational multi-center clinical trials (hereinafter – MMCTs)
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India forhigh quality, low   cost pharma solutions, CPhI & P-MEC Indiais the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India’s pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement